APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostate Cancer Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Prostate Cancer Vaccines Industry Growth and Trends Forecast to 2032

19 December 2025115 pages

Choose your research edition.

Industry ResearchProstate Cancer Vaccines Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostate Cancer Vaccines Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Prostate Cancer Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostate Cancer Vaccines Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostate Cancer Vaccines Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Prostate Cancer Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Prostate Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Prostate Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostate Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostate Cancer Vaccines include Pfizer Inc., Vaccitech, Vaccibody AS, Ultimovacs, UbiVac, SOTIO, Sensei Biotherapeutics, Oncovir Inc. and OncBioMune Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Prostate Cancer Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Prostate Cancer Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Prostate Cancer Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Prostate Cancer Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Prostate Cancer Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Prostate Cancer Vaccines Market by Company

Pfizer Inc.

Vaccitech

Vaccibody AS

Ultimovacs

UbiVac

SOTIO

Sensei Biotherapeutics

Oncovir Inc.

OncBioMune Pharmaceuticals

Momotaro-Gene Inc.

Mediolanum Farmaceutici

Medigene AG

Dendreon Corporation

Curevac AG

Cleveland BioLabs Inc.

Bavarian Nordic

AlphaVax Inc.

Advaxis immunotherapies

Advantagene

Prostate Cancer Vaccines Segment by Type

Tablet

Injection

Prostate Cancer Vaccines Segment by Application

Hospital

Clinic

Others

Prostate Cancer Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostate Cancer Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Prostate Cancer Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Injection Table 3. Global Prostate Cancer Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 5. Global Prostate Cancer Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Prostate Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Prostate Cancer Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Prostate Cancer Vaccines Price by Type (2021-2026) & (US$/Unit) Table 9. Global Prostate Cancer Vaccines Sales by Type (2027-2032) & (K Units) Table 10. Global Prostate Cancer Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Prostate Cancer Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Prostate Cancer Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Prostate Cancer Vaccines Price by Type (2027-2032) & (US$/Unit) Table 14. North America Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 15. North America Prostate Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 17. Europe Prostate Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Prostate Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 21. Latin America Prostate Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Prostate Cancer Vaccines Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Prostate Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Prostate Cancer Vaccines Industry Trends Table 25. Prostate Cancer Vaccines Industry Drivers Table 26. Prostate Cancer Vaccines Industry Opportunities and Challenges Table 27. Prostate Cancer Vaccines Industry Restraints Table 28. Global Prostate Cancer Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Prostate Cancer Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Prostate Cancer Vaccines Sales by Company (2021-2026) & (K Units) Table 31. Global Prostate Cancer Vaccines Sales Share by Company (2021-2026) Table 32. Global Prostate Cancer Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Prostate Cancer Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Prostate Cancer Vaccines Major Company Production Sites and Headquarters Table 35. Global Prostate Cancer Vaccines Company, Product Type & Application Table 36. Global Prostate Cancer Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Prostate Cancer Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Prostate Cancer Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Prostate Cancer Vaccines Sales by Region (2021-2026) & (K Units) Table 41. Global Prostate Cancer Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Prostate Cancer Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Prostate Cancer Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Prostate Cancer Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Prostate Cancer Vaccines Sales by Region (2027-2032) & (K Units) Table 46. Global Prostate Cancer Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Prostate Cancer Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Prostate Cancer Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Prostate Cancer Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Prostate Cancer Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 52. Global Prostate Cancer Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Prostate Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Prostate Cancer Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Prostate Cancer Vaccines Price by Application (2021-2026) & (US$/Unit) Table 56. Global Prostate Cancer Vaccines Sales by Application (2027-2032) & (K Units) Table 57. Global Prostate Cancer Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Prostate Cancer Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Prostate Cancer Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Prostate Cancer Vaccines Price by Application (2027-2032) & (US$/Unit) Table 61. North America Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 62. North America Prostate Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 64. Europe Prostate Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Prostate Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 68. Latin America Prostate Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Prostate Cancer Vaccines Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Prostate Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Pfizer Inc. Company Information Table 72. Pfizer Inc. Business Overview Table 73. Pfizer Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Pfizer Inc. Prostate Cancer Vaccines Product Portfolio Table 75. Pfizer Inc. Recent Development Table 76. Vaccitech Company Information Table 77. Vaccitech Business Overview Table 78. Vaccitech Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Vaccitech Prostate Cancer Vaccines Product Portfolio Table 80. Vaccitech Recent Development Table 81. Vaccibody AS Company Information Table 82. Vaccibody AS Business Overview Table 83. Vaccibody AS Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Vaccibody AS Prostate Cancer Vaccines Product Portfolio Table 85. Vaccibody AS Recent Development Table 86. Ultimovacs Company Information Table 87. Ultimovacs Business Overview Table 88. Ultimovacs Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ultimovacs Prostate Cancer Vaccines Product Portfolio Table 90. Ultimovacs Recent Development Table 91. UbiVac Company Information Table 92. UbiVac Business Overview Table 93. UbiVac Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. UbiVac Prostate Cancer Vaccines Product Portfolio Table 95. UbiVac Recent Development Table 96. SOTIO Company Information Table 97. SOTIO Business Overview Table 98. SOTIO Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. SOTIO Prostate Cancer Vaccines Product Portfolio Table 100. SOTIO Recent Development Table 101. Sensei Biotherapeutics Company Information Table 102. Sensei Biotherapeutics Business Overview Table 103. Sensei Biotherapeutics Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sensei Biotherapeutics Prostate Cancer Vaccines Product Portfolio Table 105. Sensei Biotherapeutics Recent Development Table 106. Oncovir Inc. Company Information Table 107. Oncovir Inc. Business Overview Table 108. Oncovir Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Oncovir Inc. Prostate Cancer Vaccines Product Portfolio Table 110. Oncovir Inc. Recent Development Table 111. OncBioMune Pharmaceuticals Company Information Table 112. OncBioMune Pharmaceuticals Business Overview Table 113. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product Portfolio Table 115. OncBioMune Pharmaceuticals Recent Development Table 116. Momotaro-Gene Inc. Company Information Table 117. Momotaro-Gene Inc. Business Overview Table 118. Momotaro-Gene Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Momotaro-Gene Inc. Prostate Cancer Vaccines Product Portfolio Table 120. Momotaro-Gene Inc. Recent Development Table 121. Mediolanum Farmaceutici Company Information Table 122. Mediolanum Farmaceutici Business Overview Table 123. Mediolanum Farmaceutici Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Mediolanum Farmaceutici Prostate Cancer Vaccines Product Portfolio Table 125. Mediolanum Farmaceutici Recent Development Table 126. Medigene AG Company Information Table 127. Medigene AG Business Overview Table 128. Medigene AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Medigene AG Prostate Cancer Vaccines Product Portfolio Table 130. Medigene AG Recent Development Table 131. Dendreon Corporation Company Information Table 132. Dendreon Corporation Business Overview Table 133. Dendreon Corporation Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Dendreon Corporation Prostate Cancer Vaccines Product Portfolio Table 135. Dendreon Corporation Recent Development Table 136. Curevac AG Company Information Table 137. Curevac AG Business Overview Table 138. Curevac AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Curevac AG Prostate Cancer Vaccines Product Portfolio Table 140. Curevac AG Recent Development Table 141. Cleveland BioLabs Inc. Company Information Table 142. Cleveland BioLabs Inc. Business Overview Table 143. Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Cleveland BioLabs Inc. Prostate Cancer Vaccines Product Portfolio Table 145. Cleveland BioLabs Inc. Recent Development Table 146. Bavarian Nordic Company Information Table 147. Bavarian Nordic Business Overview Table 148. Bavarian Nordic Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Bavarian Nordic Prostate Cancer Vaccines Product Portfolio Table 150. Bavarian Nordic Recent Development Table 151. AlphaVax Inc. Company Information Table 152. AlphaVax Inc. Business Overview Table 153. AlphaVax Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. AlphaVax Inc. Prostate Cancer Vaccines Product Portfolio Table 155. AlphaVax Inc. Recent Development Table 156. Advaxis immunotherapies Company Information Table 157. Advaxis immunotherapies Business Overview Table 158. Advaxis immunotherapies Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Advaxis immunotherapies Prostate Cancer Vaccines Product Portfolio Table 160. Advaxis immunotherapies Recent Development Table 161. Advantagene Company Information Table 162. Advantagene Business Overview Table 163. Advantagene Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Advantagene Prostate Cancer Vaccines Product Portfolio Table 165. Advantagene Recent Development Table 166. North America Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. North America Prostate Cancer Vaccines Sales by Country (2021-2026) & (K Units) Table 168. North America Prostate Cancer Vaccines Sales Market Share by Country (2021-2026) Table 169. North America Prostate Cancer Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 170. North America Prostate Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 171. North America Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America Prostate Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 173. North America Prostate Cancer Vaccines Market Share by Country (2021-2026) Table 174. North America Prostate Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America Prostate Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 176. Europe Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Europe Prostate Cancer Vaccines Sales by Country (2021-2026) & (K Units) Table 178. Europe Prostate Cancer Vaccines Sales Market Share by Country (2021-2026) Table 179. Europe Prostate Cancer Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 180. Europe Prostate Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 181. Europe Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe Prostate Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe Prostate Cancer Vaccines Market Share by Country (2021-2026) Table 184. Europe Prostate Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe Prostate Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Prostate Cancer Vaccines Sales by Country (2021-2026) & (K Units) Table 188. Asia-Pacific Prostate Cancer Vaccines Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific Prostate Cancer Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 190. Asia-Pacific Prostate Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Prostate Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific Prostate Cancer Vaccines Market Share by Country (2021-2026) Table 194. Asia-Pacific Prostate Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific Prostate Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 196. Latin America Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Latin America Prostate Cancer Vaccines Sales by Country (2021-2026) & (K Units) Table 198. Latin America Prostate Cancer Vaccines Sales Market Share by Country (2021-2026) Table 199. Latin America Prostate Cancer Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 200. Latin America Prostate Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America Prostate Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America Prostate Cancer Vaccines Market Share by Country (2021-2026) Table 204. Latin America Prostate Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America Prostate Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Prostate Cancer Vaccines Sales by Country (2021-2026) & (K Units) Table 208. Middle East and Africa Prostate Cancer Vaccines Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa Prostate Cancer Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 210. Middle East and Africa Prostate Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Prostate Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa Prostate Cancer Vaccines Market Share by Country (2021-2026) Table 214. Middle East and Africa Prostate Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa Prostate Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Prostate Cancer Vaccines Distributors List Table 219. Prostate Cancer Vaccines Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Prostate Cancer Vaccines Image Figure 2. Global Prostate Cancer Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostate Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Prostate Cancer Vaccines Sales (2021-2032) & (K Units) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Prostate Cancer Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Prostate Cancer Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Prostate Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Prostate Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Prostate Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Prostate Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Prostate Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Prostate Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Prostate Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Prostate Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Prostate Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Prostate Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Prostate Cancer Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Prostate Cancer Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Prostate Cancer Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Prostate Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Prostate Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Prostate Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Prostate Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Prostate Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Prostate Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Prostate Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Prostate Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Prostate Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Prostate Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Prostate Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Prostate Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Prostate Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Prostate Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Prostate Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Prostate Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Prostate Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Prostate Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Prostate Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Prostate Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Prostate Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Prostate Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Prostate Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Prostate Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Prostate Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Prostate Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Prostate Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Prostate Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Prostate Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Prostate Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Prostate Cancer Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Prostate Cancer Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Injection
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Pfizer Inc.
  • Vaccitech
  • Vaccibody AS
  • Ultimovacs
  • UbiVac
  • SOTIO
  • Sensei Biotherapeutics
  • Oncovir Inc.
  • OncBioMune Pharmaceuticals
  • Momotaro-Gene Inc.
  • Mediolanum Farmaceutici
  • Medigene AG
  • Dendreon Corporation
  • Curevac AG
  • Cleveland BioLabs Inc.
  • Bavarian Nordic
  • AlphaVax Inc.
  • Advaxis immunotherapies
  • Advantagene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prostate Cancer Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Prostate Cancer Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Prostate Cancer Vaccines Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Injection
  8. 1.4 Global Prostate Cancer Vaccines Market Size by Type
  9. 1.4.1 Global Prostate Cancer Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Prostate Cancer Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Prostate Cancer Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Prostate Cancer Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Prostate Cancer Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Prostate Cancer Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Prostate Cancer Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Prostate Cancer Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Prostate Cancer Vaccines Industry Trends
  2. 2.2 Prostate Cancer Vaccines Industry Drivers
  3. 2.3 Prostate Cancer Vaccines Industry Opportunities and Challenges
  4. 2.4 Prostate Cancer Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Prostate Cancer Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Prostate Cancer Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Prostate Cancer Vaccines Price (2021-2026)
  4. 3.4 Global Prostate Cancer Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prostate Cancer Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Prostate Cancer Vaccines Company, Product Type & Application
  7. 3.7 Global Prostate Cancer Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prostate Cancer Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prostate Cancer Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prostate Cancer Vaccines Tier 1, Tier 2, and Tier 3
4 Prostate Cancer Vaccines Regional Status and Outlook
  1. 4.1 Global Prostate Cancer Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Prostate Cancer Vaccines Historic Market Size by Region
  3. 4.2.1 Global Prostate Cancer Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Prostate Cancer Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Prostate Cancer Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Prostate Cancer Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Prostate Cancer Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Prostate Cancer Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Prostate Cancer Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Prostate Cancer Vaccines by Application
  1. 5.1 Prostate Cancer Vaccines Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Prostate Cancer Vaccines Market Size by Application
  6. 5.2.1 Global Prostate Cancer Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Prostate Cancer Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Prostate Cancer Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Prostate Cancer Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Prostate Cancer Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Prostate Cancer Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Prostate Cancer Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Prostate Cancer Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer Inc.
  2. 6.1.1 Pfizer Inc. Company Information
  3. 6.1.2 Pfizer Inc. Business Overview
  4. 6.1.3 Pfizer Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Inc. Prostate Cancer Vaccines Product Portfolio
  6. 6.1.5 Pfizer Inc. Recent Developments
  7. 6.2 Vaccitech
  8. 6.2.1 Vaccitech Company Information
  9. 6.2.2 Vaccitech Business Overview
  10. 6.2.3 Vaccitech Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Vaccitech Prostate Cancer Vaccines Product Portfolio
  12. 6.2.5 Vaccitech Recent Developments
  13. 6.3 Vaccibody AS
  14. 6.3.1 Vaccibody AS Company Information
  15. 6.3.2 Vaccibody AS Business Overview
  16. 6.3.3 Vaccibody AS Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Vaccibody AS Prostate Cancer Vaccines Product Portfolio
  18. 6.3.5 Vaccibody AS Recent Developments
  19. 6.4 Ultimovacs
  20. 6.4.1 Ultimovacs Company Information
  21. 6.4.2 Ultimovacs Business Overview
  22. 6.4.3 Ultimovacs Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ultimovacs Prostate Cancer Vaccines Product Portfolio
  24. 6.4.5 Ultimovacs Recent Developments
  25. 6.5 UbiVac
  26. 6.5.1 UbiVac Company Information
  27. 6.5.2 UbiVac Business Overview
  28. 6.5.3 UbiVac Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 UbiVac Prostate Cancer Vaccines Product Portfolio
  30. 6.5.5 UbiVac Recent Developments
  31. 6.6 SOTIO
  32. 6.6.1 SOTIO Company Information
  33. 6.6.2 SOTIO Business Overview
  34. 6.6.3 SOTIO Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SOTIO Prostate Cancer Vaccines Product Portfolio
  36. 6.6.5 SOTIO Recent Developments
  37. 6.7 Sensei Biotherapeutics
  38. 6.7.1 Sensei Biotherapeutics Company Information
  39. 6.7.2 Sensei Biotherapeutics Business Overview
  40. 6.7.3 Sensei Biotherapeutics Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sensei Biotherapeutics Prostate Cancer Vaccines Product Portfolio
  42. 6.7.5 Sensei Biotherapeutics Recent Developments
  43. 6.8 Oncovir Inc.
  44. 6.8.1 Oncovir Inc. Company Information
  45. 6.8.2 Oncovir Inc. Business Overview
  46. 6.8.3 Oncovir Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Oncovir Inc. Prostate Cancer Vaccines Product Portfolio
  48. 6.8.5 Oncovir Inc. Recent Developments
  49. 6.9 OncBioMune Pharmaceuticals
  50. 6.9.1 OncBioMune Pharmaceuticals Company Information
  51. 6.9.2 OncBioMune Pharmaceuticals Business Overview
  52. 6.9.3 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product Portfolio
  54. 6.9.5 OncBioMune Pharmaceuticals Recent Developments
  55. 6.10 Momotaro-Gene Inc.
  56. 6.10.1 Momotaro-Gene Inc. Company Information
  57. 6.10.2 Momotaro-Gene Inc. Business Overview
  58. 6.10.3 Momotaro-Gene Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Momotaro-Gene Inc. Prostate Cancer Vaccines Product Portfolio
  60. 6.10.5 Momotaro-Gene Inc. Recent Developments
  61. 6.11 Mediolanum Farmaceutici
  62. 6.11.1 Mediolanum Farmaceutici Company Information
  63. 6.11.2 Mediolanum Farmaceutici Business Overview
  64. 6.11.3 Mediolanum Farmaceutici Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Mediolanum Farmaceutici Prostate Cancer Vaccines Product Portfolio
  66. 6.11.5 Mediolanum Farmaceutici Recent Developments
  67. 6.12 Medigene AG
  68. 6.12.1 Medigene AG Company Information
  69. 6.12.2 Medigene AG Business Overview
  70. 6.12.3 Medigene AG Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Medigene AG Prostate Cancer Vaccines Product Portfolio
  72. 6.12.5 Medigene AG Recent Developments
  73. 6.13 Dendreon Corporation
  74. 6.13.1 Dendreon Corporation Company Information
  75. 6.13.2 Dendreon Corporation Business Overview
  76. 6.13.3 Dendreon Corporation Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Dendreon Corporation Prostate Cancer Vaccines Product Portfolio
  78. 6.13.5 Dendreon Corporation Recent Developments
  79. 6.14 Curevac AG
  80. 6.14.1 Curevac AG Company Information
  81. 6.14.2 Curevac AG Business Overview
  82. 6.14.3 Curevac AG Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Curevac AG Prostate Cancer Vaccines Product Portfolio
  84. 6.14.5 Curevac AG Recent Developments
  85. 6.15 Cleveland BioLabs Inc.
  86. 6.15.1 Cleveland BioLabs Inc. Company Information
  87. 6.15.2 Cleveland BioLabs Inc. Business Overview
  88. 6.15.3 Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Cleveland BioLabs Inc. Prostate Cancer Vaccines Product Portfolio
  90. 6.15.5 Cleveland BioLabs Inc. Recent Developments
  91. 6.16 Bavarian Nordic
  92. 6.16.1 Bavarian Nordic Company Information
  93. 6.16.2 Bavarian Nordic Business Overview
  94. 6.16.3 Bavarian Nordic Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Bavarian Nordic Prostate Cancer Vaccines Product Portfolio
  96. 6.16.5 Bavarian Nordic Recent Developments
  97. 6.17 AlphaVax Inc.
  98. 6.17.1 AlphaVax Inc. Company Information
  99. 6.17.2 AlphaVax Inc. Business Overview
  100. 6.17.3 AlphaVax Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 AlphaVax Inc. Prostate Cancer Vaccines Product Portfolio
  102. 6.17.5 AlphaVax Inc. Recent Developments
  103. 6.18 Advaxis immunotherapies
  104. 6.18.1 Advaxis immunotherapies Company Information
  105. 6.18.2 Advaxis immunotherapies Business Overview
  106. 6.18.3 Advaxis immunotherapies Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Advaxis immunotherapies Prostate Cancer Vaccines Product Portfolio
  108. 6.18.5 Advaxis immunotherapies Recent Developments
  109. 6.19 Advantagene
  110. 6.19.1 Advantagene Company Information
  111. 6.19.2 Advantagene Business Overview
  112. 6.19.3 Advantagene Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Advantagene Prostate Cancer Vaccines Product Portfolio
  114. 6.19.5 Advantagene Recent Developments
7 North America by Country
  1. 7.1 North America Prostate Cancer Vaccines Sales by Country
  2. 7.1.1 North America Prostate Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Prostate Cancer Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Prostate Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Prostate Cancer Vaccines Market Size by Country
  6. 7.2.1 North America Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Prostate Cancer Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Prostate Cancer Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Prostate Cancer Vaccines Sales by Country
  2. 8.1.1 Europe Prostate Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Prostate Cancer Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Prostate Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Prostate Cancer Vaccines Market Size by Country
  6. 8.2.1 Europe Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Prostate Cancer Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Prostate Cancer Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Prostate Cancer Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Prostate Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Prostate Cancer Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Prostate Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Prostate Cancer Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Prostate Cancer Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Prostate Cancer Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Prostate Cancer Vaccines Sales by Country
  2. 10.1.1 South America Prostate Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Prostate Cancer Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Prostate Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Prostate Cancer Vaccines Market Size by Country
  6. 10.2.1 South America Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Prostate Cancer Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Prostate Cancer Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Prostate Cancer Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Prostate Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Prostate Cancer Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Prostate Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Prostate Cancer Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Prostate Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Prostate Cancer Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Prostate Cancer Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Prostate Cancer Vaccines Value Chain Analysis
  2. 12.1.1 Prostate Cancer Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Prostate Cancer Vaccines Production Mode & Process
  7. 12.2 Prostate Cancer Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Prostate Cancer Vaccines Distributors
  10. 12.2.3 Prostate Cancer Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst